These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 15690394)

  • 1. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
    Pardali K; Kowanetz M; Heldin CH; Moustakas A
    J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.
    Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A
    J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
    Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
    Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
    Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
    J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition.
    Valcourt U; Kowanetz M; Niimi H; Heldin CH; Moustakas A
    Mol Biol Cell; 2005 Apr; 16(4):1987-2002. PubMed ID: 15689496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
    Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
    Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells.
    Pouliot F; Labrie C
    J Endocrinol; 2002 Jan; 172(1):187-98. PubMed ID: 11786386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
    Dennler S; Itoh S; Vivien D; ten Dijke P; Huet S; Gauthier JM
    EMBO J; 1998 Jun; 17(11):3091-100. PubMed ID: 9606191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes.
    Grönroos E; Kingston IJ; Ramachandran A; Randall RA; Vizán P; Hill CS
    Mol Cell Biol; 2012 Jul; 32(14):2904-16. PubMed ID: 22615489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
    Lee KS; Kim HJ; Li QL; Chi XZ; Ueta C; Komori T; Wozney JM; Kim EG; Choi JY; Ryoo HM; Bae SC
    Mol Cell Biol; 2000 Dec; 20(23):8783-92. PubMed ID: 11073979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lefty inhibits receptor-regulated Smad phosphorylation induced by the activated transforming growth factor-beta receptor.
    Ulloa L; Tabibzadeh S
    J Biol Chem; 2001 Jun; 276(24):21397-404. PubMed ID: 11278746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of TGF-beta related Smad proteins in human epithelial skin tumors.
    Lange D; Persson U; Wollina U; ten Dijke P; Castelli E; Heldin CH; Funa K
    Int J Oncol; 1999 Jun; 14(6):1049-56. PubMed ID: 10339656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular signaling of osteogenic protein-1 through Smad5 activation.
    Tamaki K; Souchelnytskyi S; Itoh S; Nakao A; Sampath K; Heldin CH; ten Dijke P
    J Cell Physiol; 1998 Nov; 177(2):355-63. PubMed ID: 9766532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1.
    Alliston T; Ko TC; Cao Y; Liang YY; Feng XH; Chang C; Derynck R
    J Biol Chem; 2005 Jun; 280(25):24227-37. PubMed ID: 15849193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
    Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
    Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to transforming growth factor-beta occurs in the presence of normal Smad activation.
    Berger DH; Feng XH; Yao J; Saha D; Beauchamp RD; Lin X
    Surgery; 2002 Aug; 132(2):310-6. PubMed ID: 12219028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.